Moderna mRNA Covid Vaccine - Search News

Moderna, bird flu and Influenza vaccine

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Barron's on MSN · 1d

U.S. Gives Moderna $590 Million to Accelerate a Bird Flu Vaccine

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna May Have The Best Shot At A Vaccine For Stomach Flu

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Business Insider · 23h

U.S. Awards $590 Mln To Moderna For MRNA Pandemic Influenza Vaccine Development

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to

US awards Moderna $590 million for bird flu vaccine development

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Investing.com on MSN · 1d

Moderna stock surges on bird flu vaccine funding

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a bird flu vaccine. The funding, provided by the Department of Health and Human Services,

5d

Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares tumble

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

8don MSN

A Norovirus Vaccine May Be Coming

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Amsterdam News3d

Factcheck: True: mRNA COVID-19 vaccines are safe and effective

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Zacks.com on MSN1d

How to Play Moderna Stock After the Recent Sales Guidance Cut

Given the uncertainty regarding its top-line growth, we would advise short-term investors to steer clear of MRNA stock.

2d

Is Moderna a Bad-News Buy for 2025?

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

9d

What’s Behind The Recent Rise In MRNA Stock?

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

5don MSN

Moderna Shares Plunge After Predicting Steep 2025 Sales Decline

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...

5don MSN

Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand, shares fall

Demand for its COVID vaccine has been waning after the pandemic, while adoption of its RSV shot - its second approved product ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results